Axogen, Inc. (AXGN) fundamentals score
Axogen is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It is passionate about providing the opportunity to restore nerve function and quality of life for patients with peripheral nerve injuries.
Electromedical & Electrotherapeutic Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.1 out of 10, Mixed fundamentals
- Growth: 4.9/10
- Profitability: 3.5/10
- Financial health: 7.3/10
- Earnings quality: 6.9/10
- Valuation: 3.7/10
Scores are calculated from Axogen, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10